Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line

被引:0
|
作者
Lianna Li [1 ,2 ]
Charles F. Bellows [1 ]
机构
[1] Department of Surgery, Tulane University
[2] University of Mississippi Cancer Institute
关键词
Doublecortin-like kinase 1 (DCLK1); colorectal cancer; cancer stem cells; stem cell marker; spheroids;
D O I
暂无
中图分类号
R735.35 [];
学科分类号
100214 ;
摘要
Purpose: Colon cancer stem cells (CSCs) are implicated in colorectal cancer carcinogenesis, metastasis, and therapeutic resistance. The identification of these cells could help to develop novel therapeutic strategies. Doublecortin-like kinase 1 (DCLK1) has been viewed as a marker for gastrointestinal stem cells that fuel the self-renewal process, however others view them as a marker of Tuft cells or as an enteroendocrine subtype. The purpose of this study was to use a colon cancer cell line to identify and characterize the stem-like characteristics of the DCLK1+ cell population. Methods: To enrich stem-like cells, HCT116 cells (derived from colon adenocarcinomas) were cultured using serum-free media to form spheres under both normal oxygen and hypoxia condition. DCLK1 transcript expression in the adherent parental cells and spheroids was quantified using quantitative real time reverse transcription- polymerase chain reaction [(q)RT-PCR]. DCLK1 protein expression was determined using flow cytometry. Self-renewal capability from adherent parental cells and spheroids was determined using extreme limiting dilution analysis (ELDA). Results: Under both normal oxygen and hypoxia condition, the adherent parental cells were composed of cells that express low levels of DCLK1. However, spheroids exhibited an increased frequency of cells expressing DCLK1 on both mRNA and protein levels. Cells derived from spheroids also possess stronger self-renewal capability. Conclusions: The higher fraction of DCLK1+ cells exhibited by spheroids and hypoxia reflects the stem-like characteristics of these cells. DCLK1 may represent an ideal marker to study and develop effective strategies to overcome chemo-resistance and relapse of colon cancer.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 50 条
  • [1] Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line
    Li, Lianna
    Bellows, Charles F.
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (02) : 134 - 142
  • [2] Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases
    Nguyen, Charles B.
    Houchen, Courtney W.
    Ali, Naushad
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 242 (03) : 242 - 249
  • [3] Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma
    Kadletz, Lorenz
    Thurnher, Dietmar
    Wiebringhaus, Robert
    Erovic, Boban M.
    Kotowski, Ulana
    Schneider, Sven
    Schmid, Rainer
    Kenner, Lukas
    Heiduschka, Gregor
    ORAL ONCOLOGY, 2017, 67 : 109 - 118
  • [4] Doublecortin-like kinase 2 promotes breast cancer cell invasion and metastasis
    He, Yanling
    Dai, Xiaoqin
    Li, Shengnan
    Zhang, Xinyuan
    Gong, Kunxiang
    Song, Kai
    Shi, Jian
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (04): : 1102 - 1113
  • [5] Identification of small molecule inhibitors against doublecortin-like kinase 1 for targeting colon cancer stem cells
    Mary, L. Lizha
    Gor, Ravi
    Anand, T.
    Sivaramakrishnan, V
    Satish, R.
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2024, 61 (09): : 552 - 562
  • [6] Targeting Doublecortin-like Kinase 1 (DCLK1) in Colon Cancer: An <it>In</it>-<it>silico</it> Approach
    Parsai, Janhvi
    Crockett, Cooper
    Kimball, Hunter
    Raval, Nipam
    FASEB JOURNAL, 2020, 34
  • [7] Enhanced Expression of Doublecortin-Like Kinase 1 (DCLK1) in the Background Mucosa of Colon Cancer
    Hirata, Yuki
    Sezaki, Takuhito
    Hagiwara, Teruki
    Edogawa, Shoko
    Okada, Toshihiko
    Inoue, Takuya
    Yano, Hideaki
    Gohda, Yoshimasa
    Suda, Ryuichiro
    Hirose, Yoshinobu
    Kawamura, Yutaka J.
    Higuchi, Kazuhide
    Dohi, Taeko
    Kawamura, Yuki I.
    GASTROENTEROLOGY, 2015, 148 (04) : S572 - S572
  • [8] Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma
    Standing, David
    Arnold, Levi
    Dandawate, Prasad
    Ottemann, Brendan
    Snyder, Vusala
    Ponnurangam, Sivapriya
    Sayed, Afreen
    Subramaniam, Dharmalingam
    Srinivasan, Pugazhendhi
    Choudhury, Sonali
    New, Jacob
    Kwatra, Deep
    Ramamoorthy, Prabhu
    Roy, Badal C.
    Shadoin, Melissa
    Al-Rajabi, Raed
    O'Neil, Maura
    Gunewardena, Sumedha
    Ashcraft, John
    Umar, Shahid
    Weir, Scott J.
    Tawfik, Ossama
    Padhye, Subhash B.
    Biersack, Bernhard
    Anant, Shrikant
    Thomas, Sufi Mary
    MOLECULAR CARCINOGENESIS, 2023, 62 (02) : 145 - 159
  • [9] A 15-miRNA-Surrogate Signature for Doublecortin-Like Kinase 1 Tumor Stem Cell Marker Activity Predicts Survival in Colon, Pancreatic, and Stomach Cancer
    Weygant, Nathaniel
    Ge, Yang
    Qu, Dongfeng
    May, Randal
    Chandrakesan, Parthasarathy
    Bannerman-Menson, Edwin
    Vega, Kenneth J.
    Bronze, Michael S.
    An, Guangyu
    Houchen, Courtney W.
    GASTROENTEROLOGY, 2016, 150 (04) : S607 - S608
  • [10] Doublecortin-like kinase 1-positive enterocyte - a new cell type in human intestine
    Leppanen, Joni
    Helminen, Olli
    Huhta, Heikki
    Kauppila, Joonas H.
    Miinalainen, Ilkka
    Ronkainen, Veli-Pekka
    Saarnio, Juha
    Lehenkari, Petri P.
    Karttunen, Tuomo J.
    APMIS, 2016, 124 (11) : 958 - 965